| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3802566 | Medicina Clínica | 2010 | 4 Pages |
Abstract
Enzyme replacement therapy with agalsidase beta demonstrated subjective and objective benefits related to the painful neuropathy of Fabry disease.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Juan Manuel Politei, Alberto Dubrovsky,